Not medical advice. Talk to your provider before using any peptide.
Full disclaimerPeptide Schedule Research TeamReviewed Apr 20269 Citations
Kisspeptin-1010 residuesYNWNSFGLRFEach bubble = one amino acid. Size = residue mass. Color = chemical class.Kisspeptin-10 triggers LH and testosterone release by activating the hypothalamic KISS1R receptor upstream of GnRH. Studied for fertility and post-TRT recovery, it requires cycling to avoid receptor desensitization. Community dosing runs 100 to 200 mcg subcutaneous daily or twice daily.
100mcg · Daily
Summary: Add 2mL BAC water to your 5mg vial. Draw to 4.0 units on a U-100 syringe for a 100mcg dose. This vial will last 50 doses.
View side effects and safety warnings →
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 100mcg | Daily |
| Moderate | 300mcg | Daily |
| Aggressive | 400mcg | Daily |
The math on this one matters. A 5 mg vial reconstituted with 2 mL bacteriostatic water gives you 2,500 mcg per mL, or 2.5 mcg per unit on a U-100 insulin syringe. For a 100 mcg dose, you're pulling 4 units. For 125 mcg, pull 5 units. Use BAC water specifically. Sterile water lacks the benzyl alcohol preservative, and given how fast kisspeptin-10 degrades, you want every stability advantage. Plan to use the reconstituted vial within 7 to 10 days, maybe 14 at the outside. Refrigerate immediately after mixing. Timing matters more than usual here. The subcutaneous half-life is only about 30 minutes, so inconsistent injection timing will give you inconsistent LH pulses. Most community protocols call for evening dosing, 60 to 90 minutes before bed, at the same time each day. Don't skip the day-7 LH blood draw (30 to 60 minutes post-injection). It tells you whether your vial is active and your receptors are responding.
Dosing based on No human clinical dosing data: extrapolated from research studies — 14 published references.View all sources →
Cross-check your Kisspeptin-10 reconstitution math with AI
Pricing updated 2026-04-09
Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →
Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.
Kisspeptin-10 triggers LH and testosterone release by activating the hypothalamic KISS1R receptor upstream of GnRH. Studied for fertility and post-TRT recovery, it requires cycling to avoid receptor desensitization. Community dosing runs 100 to 200 mcg subcutaneous daily or twice daily.
